Metraipolis › archive › dc_d261b052eb6f
Real-World Effectiveness and Safety of Damoctocog Alfa Pegol in Severe and Nonsevere Patients With Hemophilia A From the Prospective, Multinational, Ongoing… — Europe PMC PMID:41122986
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41122986
- DOI
- 10.1111/ejh.70026
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T03:48:26.368Z
- SHA-256 of the archived text
4d82df0a8f1e36182790aa7154088fd9bee1069f476a4f024d1c6022ce888d07- Stable URL of this page
https://metraipolis.com/documento/dc_d261b052eb6f
How to cite
Real-World Effectiveness and Safety of Damoctocog Alfa Pegol in Severe and Nonsevere Patients With Hemophilia A From the Prospective, Multinational, Ongoing… — Europe PMC PMID:41122986 — Europe PMC (en), https://europepmc.org/article/MED/41122986 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d261b052eb6f (Metraipolis archive dc_d261b052eb6f, sha256 4d82df0a8f1e36182790aa7154088fd9bee1069f476a4f024d1c6022ce888d07)
BibTeX
@misc{dcd261b052eb6f,
title = {Real-World Effectiveness and Safety of Damoctocog Alfa Pegol in Severe and Nonsevere Patients With Hemophilia A From the Prospective, Multinational, Ongoing… — Europe PMC PMID:41122986},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41122986},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d261b052eb6f; sha256 4d82df0a8f1e36182790aa7154088fd9bee1069f476a4f024d1c6022ce888d07},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41122986. Agents can read the archived copy with the MCP tool read_document.